Pharmaceuticals

Multiple Sclerosis Market in the US 2015-2019

  • TEC250865
  • 104 Pages
  • July 2015
  • Pharmaceuticals
About Multiple Sclerosis

Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems. Multiple sclerosis can be broadly classified into four types: RRMS, SPMS, PPMS, and PRMS.

Technavio's analysts forecast the multiple sclerosis market in the US to grow at a CAGR of 3.8% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the multiple sclerosis market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of multiple sclerosis.

On the basis of route of administration of the drugs, the market is grouped into the following categories:
Oral
Parenteral

On the basis of type of molecule of the drugs, the market is grouped into the following categories:
Small Molecules
Biologics

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors and competitive performances of their product portfolios in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.

Technavio's report, the multiple sclerosis market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the multiple sclerosis market in US market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors
Bayer AG
Biogen
Merck Serono
Novartis AG
Teva Pharmaceutical Industries Ltd.

Other Prominent Vendors
AB Science
Abbvie
Acorda Therapeutics
Active Biotech
Artielle
Astellas
AstraZeneca
Canbex
F. Hoffmann-La Roche
GeNeuro
GlaxoSmithKline
Glenmark
InnoBioscience Pharmaceuticals
Ipsen
Mapi-Pharma
medDay Pharmaceuticals
MediciNova
Mitsubishi Tanabe
Opexa Therapeutics
Osmotica
Pfizer
Receptos
RedHill Biopharma
Sanofi
Trophos
XenoPort

Market Driver
Unmet Medical Needs.
For a full, detailed list, view our report.

Market Challenge
Unknown Disease Etiology.
For a full, detailed list, view our report.

Market Trend
Introduction of Disease-modifying Drugs.
For a full, detailed list, view our report.

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Ovarian Cancer Drugs Market (Drugs and geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation

Ovarian cancer is cancer that affects the ovaries. According to the WHO, an estimated 2,38,700 women were diagnosed with ovarian cancer in 2012. The report analyzes the demand for ovarian ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Pharmacy Automation Systems Market (Application, End-User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Pharmacy automation system involves the automation of workflow tasks in the fields of pharmacy or healthcare, such as object counting, prescription management, compound preparation, dispensing, medication packaging and inventory management. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

Hormone Refractory Breast Cancer Asia-Pacific Market Research Report, 2013 - 2020

Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. According to the estimates of World Health Organization, cancer is the most ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Therapeutic Vaccines Market (Product, Technology, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020

Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>